The Radiographic Interpretation of Response to Avastin in Glioblastoma Multiforme
Book:
Controversies in Neuro-Oncology
Page:
74-80
Author(s):
Nicholas Butowski and Susan Chang
Index
Book:
Controversies in Neuro-Oncology
Page:
192-195
Author(s):
Bentham Science Publishers
Author Index
Book:
Controversies in Neuro-Oncology
Page:
190-191
Author(s):
Thomas C. Chen and Marc Chamberlain
Bevacizumab for Malignant Gliomas: Comparative Study with Other Malignancies
Book:
Controversies in Neuro-Oncology
Page:
184-189
Author(s):
Helen Gu and Thomas C. Chen
Cediranib in Glioblastoma
Book:
Controversies in Neuro-Oncology
Page:
176-183
Author(s):
Elizabeth R. Gerstner, Jorg H. Dietrich, Daphne Wang and Tracy T. Batchelor
Development of Sorafenib in Malignant Gliomas: Rationale and Early Clinical Experience
Book:
Controversies in Neuro-Oncology
Page:
162-170
Author(s):
Rachel Grossman and Jaishri Blakeley
Cilengitide: A Novel Integrin Antagonist, in Malignant Glioma
Book:
Controversies in Neuro-Oncology
Page:
158-161
Author(s):
L. Burt Nabors
Sunitinib for the Treatment of Central Nervous System Glioma
Book:
Controversies in Neuro-Oncology
Page:
152-157
Author(s):
Neyns Bart
The European Perspective Regarding Avastin and Malignant Gliomas
Book:
Controversies in Neuro-Oncology
Page:
147-151
Author(s):
Wolfgang Wick, Michael Platten and Antje Wick
Bevacizumab (Avastin®) and Malignant Glioma: Is there a Role? A European Perspective
Book:
Controversies in Neuro-Oncology
Page:
144-146
Author(s):
Michael Weller